GlassScriptPhysician profile
Charisse H Barta
NPI 1093737207
$22,198.56
in general payments reported to CMS, 2019-2025
86 companies · $3,336 in 2025
The $3,336 reported for 2025 was more than what 80% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,652 · 2020: $3,140 · 2021: $3,194 · 2022: $2,645 · 2023: $3,675 · 2024: $3,555 · 2025: $3,336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,566.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,878.04 | 2019-2025 | Qulipta, Duopa, Botox |
| Alexion Pharmaceuticals, INC. | $1,041.03 | 2019-2025 | Ultomiris, Soliris |
| Emd Serono, INC. | $968.64 | 2019-2025 | Mavenclad, Mavenclad |
| Novartis Pharmaceuticals Corporation | $945.94 | 2019-2025 | |
| Biogen, INC. | $875.44 | 2019-2025 | Tysabri, Vumerity |
| Genentech USA, INC. | $819.34 | 2019-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Abbott Laboratories | $795.04 | 2022-2025 | Infinity |
| Genzyme Corporation | $630.68 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $623.45 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Ucb, INC. | $614.62 | 2019-2025 | Briviact, Rystiggo |
| Amgen INC. | $563.98 | 2019-2025 | Uplizna |
| Lilly USA, LLC | $561.70 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Sunovion Pharmaceuticals INC. | $549.78 | 2019-2022 | |
| Lundbeck LLC | $525.64 | 2019-2025 | Vyepti, Rexulti |
| Allergan, INC. | $512.81 | 2019-2022 |
Show all 86 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $495.64 | 2021-2025 | |
| Sk Life Science, INC. | $455.11 | 2020-2025 | Xcopri |
| Grifols USA, LLC | $400.94 | 2019-2025 | Gamunex-C, Xembify |
| Acadia Pharmaceuticals INC | $400.15 | 2019-2025 | Nuplazid |
| Upsher-Smith Laboratories LLC | $349.29 | 2019-2023 | |
| Argenx US, INC. | $345.16 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Celgene Corporation | $339.10 | 2022-2025 | Zeposia |
| Supernus Pharmaceuticals, INC. | $329.85 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $325.06 | 2022-2025 | Ingrezza, Ongentys |
| Eisai INC. | $306.79 | 2021-2025 | |
| Merz Pharmaceuticals, LLC | $302.97 | 2021-2024 | Xeomin |
| Adamas Pharmaceuticals, INC. | $290.13 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $283.25 | 2020-2025 | Rytary, Crexont |
| Takeda Pharmaceuticals U.S.A., INC. | $278.09 | 2021-2024 | Hyqvia, Gammagard |
| Avanir Pharmaceuticals, INC. | $265.98 | 2019-2022 | |
| Microtransponder, INC. | $234.03 | 2023-2025 | |
| Alnylam Pharmaceuticals INC. | $212.19 | 2019-2023 | Onpattro |
| Otsuka America Pharmaceutical, INC. | $208.39 | 2023-2025 | Rexulti, Nuedexta |
| Boston Scientific Corporation | $176.30 | 2021-2024 | Vercise, Watchman Access System |
| Kyowa Kirin, INC. | $170.73 | 2019-2024 | Nourianz |
| Janssen Pharmaceuticals, INC | $148.59 | 2021-2022 | |
| Tg Therapeutics, INC. | $145.92 | 2023-2025 | |
| Biohaven Pharmaceuticals, INC. | $141.54 | 2020-2021 | |
| Merz North America, INC. | $137.09 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $125.39 | 2023-2024 | Aptiom |
| Jazz Pharmaceuticals INC. | $123.84 | 2022-2025 | |
| Vanda Pharmaceuticals INC. | $118.01 | 2024-2025 | Ponvory |
| Tanabe Pharma America, INC. | $113.73 | 2021-2025 | Radicava |
| Biohaven Pharmaceutical Holding Company LTD. | $111.37 | 2022 | |
| Csl Behring | $109.11 | 2020-2023 | Hizentra |
| Ge Healthcare | $108.97 | 2019-2025 | |
| Octapharma USA, INC. | $107.33 | 2022-2024 | Panzyga, Octagam Immune Globulin (Human) |
| Scilex Pharmaceuticals INC. | $106.15 | 2024-2025 | |
| Azurity Pharmaceuticals, INC. | $85.58 | 2024-2025 | Horizant |
| E.R. Squibb & Sons, L.L.C. | $75.60 | 2020-2024 | Zeposia |
| Acorda Therapeutics, INC | $75.01 | 2019-2023 | Inbrija |
| Biotronik Nro, INC. | $72.64 | 2025 | Prospera |
| Arbor Pharmaceuticals, INC. | $70.64 | 2019-2021 | |
| Zyla Life Sciences, INC. | $70.29 | 2019-2020 | |
| Horizon Therapeutics Plc | $70.26 | 2021-2023 | Uplizna |
| Mallinckrodt Enterprises LLC | $68.86 | 2019 | |
| Assertio Therapeutics, INC. | $67.98 | 2019-2020 | |
| Greenwich Biosciences, INC. | $64.94 | 2021 | |
| Mdd US Operations, LLC | $63.52 | 2020-2023 | Apokyn, Xadago, Gocovri |
| Astrazeneca Pharmaceuticals LP | $51.16 | 2022-2024 | Andexxa |
| Currax Pharmaceuticals LLC | $42.71 | 2020-2021 | |
| Impel Pharmaceuticals INC. | $42.60 | 2023 | Trudhesa |
| Aprecia Pharmaceuticals, LLC | $42.52 | 2022-2023 | Spritam |
| Aquestive Therapeutics, INC. | $41.97 | 2020-2022 | |
| Life Molecular Imaging LTD | $38.56 | 2023-2024 | Neuraceq |
| Neurelis, INC. | $35.76 | 2022-2023 | Valtoco |
| Springworks Therapeutics, INC. | $35.34 | 2024-2025 | Gomekli |
| Mallinckrodt Hospital Products INC. | $31.74 | 2020-2024 | Acthar |
| Sandoz INC. | $29.85 | 2023 | |
| Aucta Pharmaceuticals, INC. | $27.95 | 2024 | Motpoly Xr |
| Almatica Pharma LLC | $27.88 | 2021 | |
| Banner Life Sciences, LLC | $26.38 | 2023 | |
| Ipsen Biopharmaceuticals, INC | $25.76 | 2025 | Dysport |
| Avion Pharmaceuticals | $22.61 | 2022 | |
| Ns Pharma, INC. | $22.49 | 2023 | Viltepso |
| Bausch Health US, LLC | $22.17 | 2019 | |
| Kedrion Biopharma, INC. | $21.08 | 2024 | Rhogam Ultra-Filtered Plus, Albuked, Kedrab |
| Axsome Therapeutics, INC. | $20.91 | 2025 | Symbravo |
| Janssen Biotech, INC. | $19.18 | 2025 | |
| Tactile Systems Technology INC | $18.75 | 2021 | |
| Portola Pharmaceuticals, LLC | $17.78 | 2019 | |
| Promius Pharma LLC | $17.08 | 2019 | |
| Inspire Medical Systems, INC. | $15.37 | 2024 | Inspire |
| Medtronic USA, INC. | $14.98 | 2019 | |
| Tonix Medicines, INC. | $14.34 | 2025 | Zembrace Symtouch |
| Merck Sharp & Dohme LLC | $14.00 | 2019 |
Drugs and devices associated with these payments
Qulipta $1,114Ubrelvy $1,043Infinity $754Botox $567Kesimpta $353Nurtec Odt $343Tysabri $292Zeposia $291Vyepti $277Ingrezza $239Mavenclad $219Panzyga $199Leqembi $193Rexulti $191Ocrevus $189Enspryng $189Duopa $189Ultomiris $177Uplizna $166Octagam Immune Globulin (Human) $160Amyvid $159Briviact $149Vyvgart $149Briumvi $146Vyvgart Hytrulo $137Ocrevus Zunovo $136Austedo Xr $132Aptiom $125Rytary $123Rystiggo $121Ponvory $118Epidiolex $110Vumerity $109Xeomin $107Vyalev $107Ztlido $106Zavzpret $90.29Horizant $85.58Ongentys $82.59Gamunex-C $79.12Kisunla $78.85Nuplazid $77.23Nuedexta $75.29Prospera $72.64Crexont $61.03Austedo $60.95Hyqvia $60.64Radicava $59.60Onpattro $57.26Emgality $55.27Inbrija $51.17Xcopri $51.09Gammagard $47.49Trudhesa $42.60Hizentra $41.36Radicava Ors $41.07Zembrace Symtouch $39.69Neuraceq $38.56Andexxa $38.03Soliris $35.59Elyxyb - Celecoxib $35.42Vercise $29.85Nourianz $28.90Fycompa $28.38Motpoly Xr $27.95Watchman Access System $27.60Bafiertam $26.38Dysport $25.76Xembify $24.23Aubagio $22.96Exservan $22.66Xadago $22.56Apokyn $22.56Viltepso $22.49Gocovri $21.65Kedrab $21.08Rhogam Ultra-Filtered Plus $21.08Albuked $21.08Koate $21.08Gammaked $21.08Symbravo $20.91Vraylar $20.46Spritam $20.44Gomekli $18.10Inspire $15.37Valtoco $15.27Acthar $14.90
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charisse Barta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.